Modular Medical shareholders approve 150% increase in authorized shares and reverse stock split authorization

Modular Medical, Inc.

Authorized common shares increased from 100M to 250M (Proposal 3: 46.75M for, 5.04M against).
Board authorized to effect a reverse stock split at a ratio within a specified range within one year (Proposal 2: 50.6M for).
Equity incentive plan increased by 3M shares (Proposal 4: 35.38M for).
All eight director nominees elected, including CEO James Besser (not a candidate) and Duane DeSisto, Paul DiPerna, Steven Felsher, etc.
Farber Hass Hurley LLP ratified as independent auditor for fiscal year ending March 31, 2026.

item 3.03item 5.03item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.